Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2018, Article ID 2414278, 6 pages
https://doi.org/10.1155/2018/2414278
Case Report

Breast Implant-Associated Anaplastic Large Cell Lymphoma: Case Report and Review of the Literature

1Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
2Department of Pathology, Mount Sinai Downtown, New York, NY 10003, USA
3Department of Surgery, Mount Sinai Downtown, New York, NY 10003, USA
4Department of Medicine, Mount Sinai Downtown, New York, NY 10003, USA
5Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY 10029, USA
6Department of Radiation Oncology, Mount Sinai Downtown, New York, NY 10003, USA

Correspondence should be addressed to Manjeet Chadha; gro.ianistnuom@ahdahc.teejnam

Received 31 August 2017; Accepted 4 December 2017; Published 21 January 2018

Academic Editor: Sotirios G. Papageorgiou

Copyright © 2018 Eva Berlin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. The Non-Hodgkin’s Lymphoma Classification Project, “A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma,” Blood, vol. 89, no. 11, pp. 3909–3918, 1997. View at Google Scholar
  2. D. Chihara and M. A Fanale, “Management of anaplastic large cell lymphoma,” Hematology/Oncology Clinics of North America, vol. 31, no. 2, pp. 209–222, 2017. View at Publisher · View at Google Scholar
  3. E. L. Doren, R. N. Miranda, J. C. Selber et al., “U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma,” Plastic and Reconstructive Surgery, vol. 139, no. 5, pp. 1042–1050, 2017. View at Publisher · View at Google Scholar
  4. J. A. Keech Jr. and B. J. Creech, “Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant,” Plastic and Reconstructive Surgery, vol. 100, no. 2, pp. 554-555, 1997. View at Publisher · View at Google Scholar
  5. S. H. Swerdlow, E. Campo, S. A. Pileri et al., “The 2016 revision of the World Health Organization classification of lymphoid neoplasms,” Blood, vol. 127, no. 20, pp. 2375–2390, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. T. D. Cronin and F. J. Gerow, “Augmentation mammoplasty; a new “natural feel” prosthesis,” in Transactions of the Third International Congress of Plastic Surgery, vol. 66, pp. 41–49, Excerpta Medica, Amsterdam, Netherlands, 1963. View at Google Scholar
  7. ISOP Surgery, ISAPS International Survey on Aesthetic/Cosmetic Procedures Performed in 2015, June 2017, http://www.isaps.org/Media/Default/global-statistics/2016%20ISAPS%20Results.pdf.
  8. ASOP Surgeons, 2016 National Plastic Surgery Statistics, June 2017, https://d2wirczt3b6wjm.cloudfront.net/News/Statistics/2016/2016-plastic-surgery-statistics-report.pdf.
  9. R. N. Miranda, T. N. Aladily, H. M. Prince et al., “Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients,” Journal of Clinical Oncology, vol. 32, no. 2, pp. 114–20, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. C. A. Gidengil, Z. Predmore, S. Mattke, K. van Busum, and B. Kim, “Breast implant-associated anaplastic large cell lymphoma: a systematic review,” Plastic and Reconstructive Surgery, vol. 135, no. 3, pp. 713–720, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. M. W. Clemens and R. N. Miranda, “Coming of age: breast implant-associated anaplastic large cell lymphoma after 18 years of investigation,” Clinics in Plastic Surgery, vol. 42, no. 4, pp. 605–613, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. M. W. Clemens, L. J. Medeiros, C. E. Butler et al., “Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma,” Journal of Clinical Oncology, vol. 34, no. 2, pp. 160–168, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. UFAD Administration, Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), June 2017, https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm239995.htm.
  14. H. Hu, K. Johani, A. Almatroudi et al., “Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma,” Plastic and Reconstructive Surgery, vol. 137, no. 6, pp. 1659–1669, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Hu, A. Jacombs, K. Vickery, S. L. Merten, D. G. Pennington, and A. K. Deva, “Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma,” Plastic and Reconstructive Surgery, vol. 135, no. 2, pp. 319–329, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Loch-Wilkinson, K. J. Beath, R. J. W. Knight et al., “Breast implant associated anaplastic large cell lymphoma in Australia and New Zealand—high surface area textured implants are associated with increased risk,” Plastic and Reconstructive Surgery, vol. 140, no. 4, pp. 645–654, 2017. View at Publisher · View at Google Scholar
  17. M. E. Kadin, A. Deva, H. Xu et al., “Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma,” Aesthetic Surgery Journal, vol. 36, no. 7, pp. 773–781, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Hart and M. J. Lechowicz, “Breast implant-associated anaplastic large cell lymphoma: treatment experience in 53 patients,” Blood, vol. 122, no. 21, p. 5089, 2013. View at Google Scholar
  19. The Plastic Surgery Foundation, Frequently Asked Questions (FAQ): A Guide to Breast Implant-Associated Anaplastic Large Cell Lymphoma, 2017, https://www.thepsf.org/Documents/Clinical/PROFILE/profile-faq.pdf.
  20. M. W. Clemens and S. M Horwitz, “NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma,” Aesthetic Surgery Journal, vol. 37, no. 3, pp. 285–289, 2017. View at Publisher · View at Google Scholar
  21. A. Zimmerman, F. L. Locke, J. Emole et al., “Recurrent systemic anaplastic lymphoma kinase-negative anaplastic large cell lymphoma presenting as a breast implant-associated lesion,” Cancer Control, vol. 22, no. 3, pp. 369–373, 2015. View at Publisher · View at Google Scholar
  22. M. J. Hwang, H. Brown, R. Murrin, N. Momtahan, and G. D. Sterne, “Breast implant-associated anaplastic large cell lymphoma: a case report and literature review,” Aesthetic Plastic Surgery, vol. 39, no. 3, pp. 391–395, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Parthasarathy, J. Orrell, C. Mortimer, and L. Ball, “Chemotherapy-resistant breast implant-associated anaplastic large cell lymphoma,” BMJ Case Reports, vol. 2013, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. C. Tardio and R. Granados, “Axillary lymphadenopathy: an outstanding presentation for breast implant-associated ALK-negative anaplastic large cell lymphoma,” International Journal of Surgical Pathology, vol. 23, no. 5, pp. 424–428, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. MA. Bautista-Quach, A. Nademanee, D. D. Weisenburger, W. Chen, and Y. S. Kim, “Implant-associated primary anaplastic large-cell lymphoma with simultaneous involvement of bilateral breast capsules,” Clinical Breast Cancer, vol. 13, no. 6, pp. 492–495, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. E. V. George, J. Pharm, C. Houston et al., “Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis,” International Journal of Clinical and Experimental Pathology, vol. 6, no. 8, pp. 1631–1642, 2013. View at Google Scholar
  27. I. M. De Silva, J. A. Teague, and W. E. Blake, “Breast implant associated anaplastic large cell lymphoma: a case report and reconstructive option,” Journal of Plastic, Reconstructive, and Aesthetic Surgery, vol. 66, no. 12, pp. 1773–1776, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. T. J. Smith and R Ramsaroop, “Breast implant related anaplastic large cell lymphoma presenting as late onset peri-implant effusion,” Breast, vol. 21, no. 1, pp. 102–104, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. A. K. Wong, J. Lopategui, S. Clancy, D. Kulber, and S. Bose, “Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature,” American Journal of Surgical Pathology, vol. 32, no. 8, pp. 1265–1268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Sorensen, J. Murphy, A. Lennard, V. Wadehra, G. K. Menon, and N. Collis, “Anaplastic large cell lymphoma in a reconstructed breast using a silicone implant: a UK case report,” Journal of Plastic, Reconstructive, and Aesthetic Surgery, vol. 67, no. 4, pp. 561–563, 2014. View at Publisher · View at Google Scholar · View at Scopus